• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

大鼠胶质瘤中髓样抑制细胞对T细胞激活的反应及其肿瘤浸润情况

Tumor infiltration by myeloid suppressor cells in response to T cell activation in rat gliomas.

作者信息

Graf Martin R, Sauer Jeremy T, Merchant Randall E

机构信息

Department of Neurosurgery, Virginia Commonwealth University Medical Center, Richmond, Virginia, 23298-0631, USA.

出版信息

J Neurooncol. 2005 May;73(1):29-36. doi: 10.1007/s11060-007-9442-z.

DOI:10.1007/s11060-007-9442-z
PMID:15933813
Abstract

We have recently reported that activation of tumor-specific T cells by subcutaneous vaccination with irradiated T9 glioma cells of syngeneic rats with a pre-existing, intracranial (i.c.) T9 glioma (T9+vaccination) promotes the mobilization of myeloid suppressor cells (MSC) which inhibit T cell function resulting in unregulated tumor progression. The current study investigated if this immunological paradigm could be recapitulated in T cell deficient rats, in other rat glioma models or using a dendritic cell (DC) vaccine. When nude rats were used in the T9+vaccination model, the level of MSC tumor infiltration remained low in vaccinated and control groups and there was no significant difference in tumor size between the groups. Increased tumor infiltration by MSC after vaccination with respective irradiated tumor cells was observed in the 9L, F98 and D74 gliomas. RT-2 tumors were markedly infiltrated with MSC regardless of vaccination. Enhanced tumor progression in response to immunization and T cell activation was observed in rats bearing F98 and D74 gliomas, although less pronounced than in the T9 model, and there was a trend for increased tumor size in the 9L glioma model. Increased MSC infiltrate and augmented T9 glioma growth were observed when DC pulsed with T9 cell lysate was used as a vaccine. These results suggest that MSC infiltration and unregulated tumor growth in response to vaccination is T cell-dependent; is not unique to the T9 glioma; and can be recapitulated with an alternate immunization approach.

摘要

我们最近报道,对预先存在颅内T9胶质瘤的同基因大鼠皮下接种经照射的T9胶质瘤细胞(T9 + 疫苗接种)来激活肿瘤特异性T细胞,会促进髓系抑制细胞(MSC)的动员,而这些细胞会抑制T细胞功能,导致肿瘤进展失控。当前研究调查了这种免疫模式是否能在T细胞缺陷大鼠、其他大鼠胶质瘤模型中重现,或者使用树突状细胞(DC)疫苗来重现。在T9 + 疫苗接种模型中使用裸鼠时,接种组和对照组中MSC肿瘤浸润水平仍然较低,两组之间肿瘤大小没有显著差异。在9L、F98和D74胶质瘤模型中,接种相应经照射的肿瘤细胞后观察到MSC肿瘤浸润增加。无论是否接种疫苗,RT - 2肿瘤均有明显的MSC浸润。在携带F98和D74胶质瘤的大鼠中,观察到免疫和T细胞激活后肿瘤进展增强,尽管不如T9模型明显,并且在9L胶质瘤模型中存在肿瘤大小增加的趋势。当使用用T9细胞裂解物脉冲处理的DC作为疫苗时,观察到MSC浸润增加和T9胶质瘤生长加剧。这些结果表明,接种疫苗后MSC浸润和肿瘤生长失控是T细胞依赖性的;并非T9胶质瘤所特有;并且可以通过另一种免疫方法重现。

相似文献

1
Tumor infiltration by myeloid suppressor cells in response to T cell activation in rat gliomas.大鼠胶质瘤中髓样抑制细胞对T细胞激活的反应及其肿瘤浸润情况
J Neurooncol. 2005 May;73(1):29-36. doi: 10.1007/s11060-007-9442-z.
2
Irradiated tumor cell vaccine for treatment of an established glioma. II. Expansion of myeloid suppressor cells that promote tumor progression.用于治疗已形成的神经胶质瘤的辐照肿瘤细胞疫苗。II. 促进肿瘤进展的髓样抑制细胞的扩增。
Cancer Immunol Immunother. 2002 Jun;51(4):190-9. doi: 10.1007/s00262-002-0270-x. Epub 2002 Apr 6.
3
Irradiated tumor cell vaccine for treatment of an established glioma. I. Successful treatment with combined radiotherapy and cellular vaccination.用于治疗已形成的神经胶质瘤的辐照肿瘤细胞疫苗。I. 联合放疗和细胞疫苗接种的成功治疗
Cancer Immunol Immunother. 2002 Jun;51(4):179-89. doi: 10.1007/s00262-002-0269-3. Epub 2002 Apr 4.
4
Tumor-infiltrating, myeloid-derived suppressor cells inhibit T cell activity by nitric oxide production in an intracranial rat glioma + vaccination model.在颅内大鼠脑胶质瘤+疫苗接种模型中,肿瘤浸润性髓系来源的抑制细胞通过一氧化氮产生抑制 T 细胞活性。
J Neuroimmunol. 2010 Jun;223(1-2):20-30. doi: 10.1016/j.jneuroim.2010.03.011. Epub 2010 May 8.
5
Antiangiogenic drugs synergize with a membrane macrophage colony-stimulating factor-based tumor vaccine to therapeutically treat rats with an established malignant intracranial glioma.抗血管生成药物与基于膜巨噬细胞集落刺激因子的肿瘤疫苗协同作用,用于治疗患有已形成的恶性颅内胶质瘤的大鼠。
J Immunol. 2005 Mar 1;174(5):2533-43. doi: 10.4049/jimmunol.174.5.2533.
6
Phenotype and functional activity of tumor-infiltrating lymphocytes isolated from immunogenic and nonimmunogenic rat brain tumors.从免疫原性和非免疫原性大鼠脑肿瘤中分离出的肿瘤浸润淋巴细胞的表型和功能活性。
Cancer Res. 1991 May 1;51(9):2373-8.
7
Effects of syngeneic cellular vaccinations alone or in combination with GM-CSF on the weakly immunogenic F98 glioma model.同基因细胞疫苗单独或与粒细胞-巨噬细胞集落刺激因子联合应用对低免疫原性F98胶质瘤模型的影响。
J Neurooncol. 2006 Aug;79(1):9-17. doi: 10.1007/s11060-005-9115-8. Epub 2006 Mar 31.
8
T9 glioma cells expressing membrane-macrophage colony stimulating factor produce CD4+ T cell-associated protective immunity against T9 intracranial gliomas and systemic immunity against different syngeneic gliomas.表达膜型巨噬细胞集落刺激因子的T9胶质瘤细胞可产生针对T9颅内胶质瘤的CD4 + T细胞相关保护性免疫以及针对不同同基因胶质瘤的全身免疫。
Cell Immunol. 2002 Jan;215(1):1-11. doi: 10.1016/s0008-8749(02)00011-4.
9
Glioma-specific cytotoxic T cells can be effectively induced by subcutaneous vaccination of irradiated wild-type tumor cells without artificial cytokine production.通过皮下接种经辐照的野生型肿瘤细胞,无需人工产生细胞因子,即可有效诱导胶质瘤特异性细胞毒性T细胞。
Int J Oncol. 2003 Aug;23(2):483-8.
10
Cellular antitumor immune response to a branched lysine multiple antigenic peptide containing epitopes of a common tumor-specific antigen in a rat glioma model.大鼠胶质瘤模型中对含常见肿瘤特异性抗原表位的支链赖氨酸多抗原肽的细胞抗肿瘤免疫反应
Cancer Immunol Immunother. 2005 Feb;54(2):107-19. doi: 10.1007/s00262-004-0576-y. Epub 2004 Aug 31.

引用本文的文献

1
Glioma immunotherapy enhancement and CD8-specific sialic acid cleavage by isocitrate dehydrogenase (IDH)-1.通过异柠檬酸脱氢酶 1(IDH-1)增强神经胶质瘤免疫治疗和 CD8 特异性唾液酸裂解。
Oncogene. 2023 Jun;42(25):2088-2098. doi: 10.1038/s41388-023-02713-7. Epub 2023 May 9.
2
Dynamic changes in trauma-induced myeloid-derived suppressor cells after polytrauma are associated with an increased susceptibility to infection.多发伤后创伤诱导的髓源性抑制细胞的动态变化与感染易感性增加有关。
Int J Clin Exp Pathol. 2017 Nov 1;10(11):11063-11068. eCollection 2017.
3
CD4+ and Perivascular Foxp3+ T Cells in Glioma Correlate with Angiogenesis and Tumor Progression.

本文引用的文献

1
Time course analysis and modulating effects of established brain tumor on active-specific immunotherapy.
Neurosurg Focus. 2000 Dec 15;9(6):e3. doi: 10.3171/foc.2000.9.6.4.
2
Contrasting effects of interleukin-2 secretion by rat glioma cells contingent upon anatomical location: accelerated tumorigenesis in the central nervous system and complete rejection in the periphery.大鼠胶质瘤细胞分泌白细胞介素-2的效果因解剖位置而异:在中枢神经系统中加速肿瘤发生,而在周围组织中则完全被排斥。
J Neuroimmunol. 2003 Jul;140(1-2):49-60. doi: 10.1016/s0165-5728(03)00167-x.
3
7-Hydroxystaurosporine-induced apoptosis in 9L glioma cells provides an effective antigen source for dendritic cells and yields a potent vaccine strategy in an intracranial glioma model.7-羟基星形孢菌素诱导9L胶质瘤细胞凋亡可为树突状细胞提供有效的抗原来源,并在颅内胶质瘤模型中产生有效的疫苗策略。
胶质瘤中的CD4 +和血管周围Foxp3 + T细胞与血管生成和肿瘤进展相关。
Front Immunol. 2017 Nov 7;8:1451. doi: 10.3389/fimmu.2017.01451. eCollection 2017.
4
Guidelines for the welfare and use of animals in cancer research.癌症研究中动物福利和使用的指南。
Br J Cancer. 2010 May 25;102(11):1555-77. doi: 10.1038/sj.bjc.6605642.
5
Tumor-infiltrating, myeloid-derived suppressor cells inhibit T cell activity by nitric oxide production in an intracranial rat glioma + vaccination model.在颅内大鼠脑胶质瘤+疫苗接种模型中,肿瘤浸润性髓系来源的抑制细胞通过一氧化氮产生抑制 T 细胞活性。
J Neuroimmunol. 2010 Jun;223(1-2):20-30. doi: 10.1016/j.jneuroim.2010.03.011. Epub 2010 May 8.
6
Normal human monocytes exposed to glioma cells acquire myeloid-derived suppressor cell-like properties.正常人类单核细胞暴露于神经胶质瘤细胞后获得髓系来源的抑制细胞样特性。
Neuro Oncol. 2010 Apr;12(4):351-65. doi: 10.1093/neuonc/nop023. Epub 2009 Dec 22.
7
Dendritic cell therapy of high-grade gliomas.高级别胶质瘤的树突状细胞疗法。
Brain Pathol. 2009 Oct;19(4):694-712. doi: 10.1111/j.1750-3639.2009.00316.x.
8
Immunotherapy of diffuse gliomas: biological background, current status and future developments.弥漫性胶质瘤的免疫治疗:生物学背景、现状与未来发展
Brain Pathol. 2009 Oct;19(4):674-93. doi: 10.1111/j.1750-3639.2009.00315.x.
9
Therapeutic vaccines for malignant brain tumors.用于恶性脑肿瘤的治疗性疫苗。
Biologics. 2008 Dec;2(4):753-61. doi: 10.2147/btt.s3197.
10
Experimental manipulations of afferent immune responses influence efferent immune responses to brain tumors.传入免疫反应的实验性操作会影响对脑肿瘤的传出免疫反应。
Cancer Immunol Immunother. 2008 Sep;57(9):1323-33. doi: 10.1007/s00262-008-0467-8. Epub 2008 Feb 16.
Neurosurgery. 2002 Jun;50(6):1327-34; discussion 1334-5. doi: 10.1097/00006123-200206000-00025.
4
Irradiated tumor cell vaccine for treatment of an established glioma. II. Expansion of myeloid suppressor cells that promote tumor progression.用于治疗已形成的神经胶质瘤的辐照肿瘤细胞疫苗。II. 促进肿瘤进展的髓样抑制细胞的扩增。
Cancer Immunol Immunother. 2002 Jun;51(4):190-9. doi: 10.1007/s00262-002-0270-x. Epub 2002 Apr 6.
5
Irradiated tumor cell vaccine for treatment of an established glioma. I. Successful treatment with combined radiotherapy and cellular vaccination.用于治疗已形成的神经胶质瘤的辐照肿瘤细胞疫苗。I. 联合放疗和细胞疫苗接种的成功治疗
Cancer Immunol Immunother. 2002 Jun;51(4):179-89. doi: 10.1007/s00262-002-0269-3. Epub 2002 Apr 4.
6
Analysis of maturation states of rat bone marrow-derived dendritic cells using an improved culture technique.使用改进培养技术分析大鼠骨髓来源树突状细胞的成熟状态
Histochem Cell Biol. 2002 Apr;117(4):351-62. doi: 10.1007/s00418-002-0384-4. Epub 2002 Feb 16.
7
Myeloid suppressor lines inhibit T cell responses by an NO-dependent mechanism.髓系抑制细胞系通过一种依赖一氧化氮的机制抑制T细胞反应。
J Immunol. 2002 Jan 15;168(2):689-95. doi: 10.4049/jimmunol.168.2.689.
8
Tumor-induced immune dysfunctions caused by myeloid suppressor cells.髓系抑制细胞引起的肿瘤诱导的免疫功能障碍。
J Immunother. 2001 Nov-Dec;24(6):431-46. doi: 10.1097/00002371-200111000-00001.
9
Mechanism of immune dysfunction in cancer mediated by immature Gr-1+ myeloid cells.未成熟Gr-1+髓样细胞介导的癌症免疫功能障碍机制
J Immunol. 2001 May 1;166(9):5398-406. doi: 10.4049/jimmunol.166.9.5398.
10
Vaccination of malignant glioma patients with peptide-pulsed dendritic cells elicits systemic cytotoxicity and intracranial T-cell infiltration.用肽脉冲树突状细胞对恶性胶质瘤患者进行疫苗接种可引发全身细胞毒性和颅内T细胞浸润。
Cancer Res. 2001 Feb 1;61(3):842-7.